KEEP FOLLOWING THE STORY
LLY news & interviews.
Lilly Reports Second-Quarter 2026 Results and Raises Full-Year Guidance
Read the original announcement and examine the details behind the headline.
Read the story
YOUTUBE INTERVIEWEli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook
In conversation with David Ricks, Eli Lilly chairman and CEO at the time of the interview.
Watch on YouTubeLinks checked Sep 23, 2026. Company news is published by the company; interviews reflect the recording date and may feature former leaders. These are selected links, not a live news feed.
The stories on our desk.
Health & financeLilly completes AtaiBeckley acquisition, adding a neuroscience pipeline
The acquisition brings investigational mental-health programs, including BPL-003 for treatment-resistant depression.
Who’s behind the business?
David Ricks
Chair and Chief Executive Officer
Sources & date
Role checked 2026-09-23. Photo: Eli Lilly and Company. Inclusion does not imply endorsement.
Review the leadership biography alongside the annual report, compensation disclosures and governance materials. Social posts are not a substitute for filings.
The business, in a sentence.
Research, development and commercialization of medicines.
The question to investigate.
How do manufacturing capacity, trial outcomes, pricing and product concentration affect the long-term growth case?
Risks to examine.
Review competitive pressure, valuation expectations, execution, regulation, financing and exposure to the economic cycle. These are research topics, not an exhaustive assessment.
Build a dated research record
0 / 5 reviewedShared business exposures
These connections use editorial theme tags. They are not measured return correlations, supplier confirmations or trade recommendations.